Novo Nordisk  

Eye Damage

Detection and surveillance

Detection and surveillance of eye problems are a routine part of Annual Review
Organize a recall system to ensure it occurs regularly for every individual

Measure or assess yearly :

visual acuity ( glasses or pinhole )

the lens and vitreous ( ophthalmoscopy )

the retina ( dilated pupils, retinal photography or skilled ophthalmoscopy )

related factors ( smoking / blood pressure )

Reassess after shorter interval ( 3-6 mo ) if :

pregnant ( see below )

new or progressive early or moderate non-proliferative retinopathy

blood glucose control recently improved
Eye disease management

Refer to ophthalmologist if :

severe non-proliferative retinopathy

proliferative retinopathy

macular oedema or exudative maculopathy

visual disability from cataract

unexplained deterioration of visual acuity

other eye disease of visual significance

unrecognized eye lesions

Review and intensify management of :

diabetic kidney disease

blood pressure ( target <135/85 mmHg, or lower if kidney damage )

blood glucose control

blood lipid control ( if hard exudates )

smoking

Attend to the psychological and social aspects of visual impairment where it develops
The primary management of diabetic eye disease is by careful attention to blood glucose control targets from the time of diagnosis

 

Foot Problems

 

IDF Guidelines to Type 1 diabetes
Click here for 'Topic Finder'

Click here for 'Ensure effective delivery of care'
Click here for 'Promote effective self-care'
Click here for 'Control blood glucose, blood lipids, arterial factors'
Detect and manage diabetes complications
Kidney Damage
Eye Damage
Foot Problems
Nerve Damage
Click here for 'Manage special problems'
Click here for 'Index'



Novo Nordisk Click here to return to the top of the page